Casdin-Capital

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
44
Total Value
1223806401
Accession Number
0000919574-25-003248
Form Type
13F-HR
Manager Name
Casdin-Capital
Data Enrichment
95% identified
42 identified2 unidentified

Holdings

44 positions
Manager:
Search and click to pin securities to the top
Page 3 of 3
Monte Rosa Therapeutics, Inc.
Shares:86.0K
Value:$399.1K
Ginkgo Bioworks Holdings, Inc.
Shares:36.5K
Value:$208.0K
Tango Therapeutics, Inc.
Shares:125.0K
Value:$171.3K
Kronos Bio, Inc.
Shares:123.8K
Value:$102.2K